The RNA expression analysis of ERRFI1 showed a two-fold increase in unfavourable tumour compared to favourable, seemingly contradicting the results of another study that found ERRFI1 downregulation in breast tumours in patients with poor prognosis (Amatschek et al, 2004). This evidence concerns the gene ERRFI1 and neoplasm.